AMPLIMUNE
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 30 Aug 2024)
What this means for you
Registered since 23 Jan 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86613515
- Registration number
- 5383140
- Mark type
- Stylized text
- Filed
- 29 Apr 2015
- Published for opposition
- 07 Nov 2017
- Registered
- 23 Jan 2018
- Attorney of record
- Stephen R. Barrese
Goods and services
- Class 005 — Pharmaceuticals: An immunotherapeutic agent for the treatment of ruminants, namely, for the treatment of neonatal and juvenile diseases; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea in neonates
Owner
- Novavive Inc., Belleville, Ontario, CA
- Novavive Inc., Belleville, Ontario, CA
- Novavive Inc., Belleville, Ontario, CA
Prosecution history
- 30 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 30 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 08 Aug 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 25 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Jan 2024 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jan 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 23 Jan 2018 — REGISTERED-PRINCIPAL REGISTER
- 07 Nov 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Nov 2017 — PUBLISHED FOR OPPOSITION
- 18 Oct 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Oct 2017 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 02 Oct 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 02 Oct 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Oct 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE